MYC and cancer: For example, VPS9D1-AS1, a known Wnt/MYC target, was both Wnt-activated in our study and also upregulated in 11 different types of cancers (Additional file 1: Fig. S2C), consistent with its established role as a lncRNA with oncogenic function [27].